Editas Medicine to participate in September investor conferences
Editas Medicine said management will participate in upcoming investor conferences in September.
CAMBRIDGE, Mass., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc.
NASDAQ:EDIT, a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in September…